Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Current treatments span a spectrum of non-invasive to highly invasive options and include medical and surgical variants. The success of the MAZE procedure and its successors has led to the development of surgical ablation devices designed to mark cardiac tissue in a manner similar to suture lines, thereby disrupting the path of the electrical impulses causing the patient’s AF
In terms of region, the largest segment of Atrial Fibrillation Surgery Devices Market would be North America, with a market share of over 40％ in 2019. The follower is Europe accounted for nearly 27％ of global market.
For the major players of Atrial Fibrillation Surgery Devices, Johnson & Johnson maintained its first place in the ranking in 2019. Followed by Abbott，Medtronic，Japan Lifeline，Boston Scientific etc.. The Top 5 players accounted for about 86％ of the Atrial Fibrillation Surgery Devices revenue market share in 2019.
The global Atrial Fibrillation Surgery Devices market was valued at US$ 1892 million in 2019 and is expected to reach US$ 3087.2 million by the end of 2026, growing at a CAGR of 9.9% during 2021-2026.
This report focuses on Atrial Fibrillation Surgery Devices volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Atrial Fibrillation Surgery Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Atrial Fibrillation Surgery Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Catheter Ablation
Maze Surgery
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Johnson & Johnson
Abbott
Medtronic
Japan Lifeline
Boston Scientific
Atricure
Biotroik
OSYPKA AG
Cardiofocus
MicroPort EP MedTech
Synaptic Medical
In terms of region, the largest segment of Atrial Fibrillation Surgery Devices Market would be North America, with a market share of over 40％ in 2019. The follower is Europe accounted for nearly 27％ of global market.
For the major players of Atrial Fibrillation Surgery Devices, Johnson & Johnson maintained its first place in the ranking in 2019. Followed by Abbott，Medtronic，Japan Lifeline，Boston Scientific etc.. The Top 5 players accounted for about 86％ of the Atrial Fibrillation Surgery Devices revenue market share in 2019.
The global Atrial Fibrillation Surgery Devices market was valued at US$ 1892 million in 2019 and is expected to reach US$ 3087.2 million by the end of 2026, growing at a CAGR of 9.9% during 2021-2026.
This report focuses on Atrial Fibrillation Surgery Devices volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Atrial Fibrillation Surgery Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Atrial Fibrillation Surgery Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Catheter Ablation
Maze Surgery
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Johnson & Johnson
Abbott
Medtronic
Japan Lifeline
Boston Scientific
Atricure
Biotroik
OSYPKA AG
Cardiofocus
MicroPort EP MedTech
Synaptic Medical
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
